Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Malignant Lymphoma

Free Subscription 06.10.2025 1 BMC Cancer 3 BMC Neurol 1 Bone Marrow Transplant 4 Br J Haematol 2 Haematologica 3 J Clin Oncol 2 Leuk Lymphoma 1 Leukemia 1 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. NIGUSIE M, Adam H, Weitzman S, Kassahun A, et al
   Early treatment-related morbidity and mortality of children with non-Hodgkin's lymphoma treated at Tikur Anbesa Specialized Hospital with modified ALCL protocol: prospective cohort study.
   BMC Cancer. 2025;25:1446.
   PubMed         Abstract available
   
   

   
   BMC Neurol

2. MA J, Song D, Yu X, Wang T, et al
   Intravascular large B-cell lymphoma presenting as encephalomyelitis diagnosed by renal biopsy: a case report.
   BMC Neurol. 2025;25:389.
   PubMed         Abstract available
   
   
3. IGUCHI T, Furuya T, Koinuma T, Nakajima A, et al
   Lymphomatosis cerebri presenting with rapidly progressive parkinsonism and Holmes tremor: a case report.
   BMC Neurol. 2025;25:392.
   PubMed         Abstract available
   
   
4. JIANG Z, Zhu Z, Tao Z, Niu F, et al
   Primary intracranial plasmablastic lymphoma with intradural extramedullary metastasis: a case report.
   BMC Neurol. 2025;25:394.
   PubMed         Abstract available
   
   

   
   Bone Marrow Transplant

5. TORRENT A, Morgades M, Iacoboni G, Reguera JL, et al
   Patient selection and treatment outcomes over time in patients with large B-cell lymphoma receiving car T-cell therapy.
   Bone Marrow Transplant. 2025 Sep 30. doi: 10.1038/s41409-025-02722.
   PubMed        
   
   

   
   Br J Haematol

6. CHIRIAC R, Baseggio L
   Reed-Sternberg-like cells in central nervous system relapse of diffuse large B-cell lymphoma.
   Br J Haematol. 2025 Oct 2. doi: 10.1111/bjh.70174.
   PubMed        
   
   
7. SUH M, Hyung J, Park CS, Go H, et al
   Prognostic significance of pretransplant (18)F-FDG PET/CT metrics in relapsed/refractory diffuse large B-cell lymphoma with partial response to salvage chemotherapy prior to autologous stem cell transplantation.
   Br J Haematol. 2025 Oct 1. doi: 10.1111/bjh.70186.
   PubMed         Abstract available
   
   
8. SHENG X, Wang D, Li S, Li B, et al
   Targeting small ubiquitin-related modifier-specific protease 2 attenuates tumour progression and orchestrates the tumour immune microenvironment in diffuse large B-cell lymphoma.
   Br J Haematol. 2025 Oct 1. doi: 10.1111/bjh.70187.
   PubMed         Abstract available
   
   
9. KALASHNIKOV I, Reunamo T, Tanskanen T, Viisanen L, et al
   Transformation and causes of death in follicular lymphoma: A Finnish nationwide population-based study.
   Br J Haematol. 2025 Sep 25. doi: 10.1111/bjh.70181.
   PubMed         Abstract available
   
   

   
   Haematologica

10. CHUNG E, Wang L, Wellard C, Barraclough A, et al
    Prognostic value of tumor bulk in modern management of common lymphoma subtypes: an Australasian Lymphoma and Related Diseases Registry study.
    Haematologica. 2025 Sep 25. doi: 10.3324/haematol.2025.287919.
    PubMed         Abstract available
    
    
11. YANG J, Hayden AR, Villa D, Jiang A, et al
    Utility of the Central Nervous System International Prognostic Index in patients with primary mediastinal large B-cell lymphoma treated with rituximab-containing chemoimmunotherapy.
    Haematologica. 2025 Oct 2. doi: 10.3324/haematol.2025.288699.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

12. BUDDE LE, Zhang H, Kim WS, Maruyama D, et al
    Mosunetuzumab plus polatuzumab vedotin in transplant-ineligible refractory/relapsed large B-cell lymphoma: primary results of the phase 3 SUNMO trial.
    J Clin Oncol. 2025 Oct 2:101200JCO2501957. doi: 10.1200/JCO-25-01957.
    PubMed         Abstract available
    
    
13. GALLAMINI A, Tarella C, Viviani S, Rossi A, et al
    Erratum: Early Chemotherapy Intensification With Escalated BEACOPP in Patients With Advanced-Stage Hodgkin Lymphoma With a Positive Interim Positron Emission Tomography/Computed Tomography Scan After Two ABVD Cycles: Long-Term Results of the GITIL/FIL
    J Clin Oncol. 2025 Sep 26:JCO2502137. doi: 10.1200/JCO-25-02137.
    PubMed        
    
    
14. MORSCHHAUSER F, Salles G, Sehn LH, Herrera AF, et al
    Five-Year Outcomes of the POLARIX Study Comparing Pola-R-CHP and R-CHOP in Patients With Diffuse Large B-Cell Lymphoma.
    J Clin Oncol. 2025 Sep 24:JCO2500925. doi: 10.1200/JCO-25-00925.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

15. MASUCCI L, Kuruvilla J, Sander B, Prica A, et al
    Real-world healthcare costs for patients treated with chimeric antigen receptor T-cell therapy in Canada.
    Leuk Lymphoma. 2025;66:1875-1883.
    PubMed         Abstract available
    
    
16. ZHONG M, Liu H, Gui R, Zhang J, et al
    Progression of disease within 6 months: revised early disease progression threshold for ENKTL.
    Leuk Lymphoma. 2025;66:1893-1902.
    PubMed         Abstract available
    
    

    
    Leukemia

17. ZHANG J, Wang D, Luan M, Liu X, et al
    Liquid-liquid phase separation of ZHX2 protects DLBCL cells against ferroptosis through induction of SLC3A2.
    Leukemia. 2025;39:2442-2451.
    PubMed         Abstract available
    
    

    
    PLoS One

18. ANTONUCCI A, Lucas AR, Costa J, Norton S, et al
    Physical activity is associated with exercise capacity among patients undergoing chemotherapy: A pilot randomized controlled trial.
    PLoS One. 2025;20:e0329774.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge.